Corbus Pharmaceuticals Holding (CRBP NASDAQ) stock market data APIs
$4.0111
0.07(1.7%)
as of October 26, 2026
Try our APIs with
free plan!
Corbus Pharmaceuticals Holding Financial Data Overview
Price chart is built with
Anychart
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Prev. Close
4.0111
Open
4.0849
High
4.1081
Low
3.8839
52 wk Range
3.87-17.75
Market Cap
77 172 K
Shares Outstanding
19 341 K
EPS
-1.81
Beta
2.632
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Corbus Pharmaceuticals Holding (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Corbus Pharmaceuticals Holding data using free add-ons & libraries
Get Corbus Pharmaceuticals Holding Fundamental Data
Corbus Pharmaceuticals Holding Fundamental data includes:
- Net Revenue:
- EBITDA: -106 678 000
- Earnings Per Share: -6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Corbus Pharmaceuticals Holding Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -1.3
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Corbus Pharmaceuticals Holding News
New
Is CRBP a Good Cannabis Investment After Positive Obesity Study Data?
Corbus Pharmaceuticals CRBP has emerged as an unusual way for investors to gain exposure to the cannabis space. The company recently announced positive results from an early-stage study on its obesity...
Biotech Stock Gainers: CODX Extends Rally, SBFM Surges, GOVX Ebola Strategy, RGNX Awaits Catalysts
(RTTNews) - Today's gainers include CODX, which rallied for the third straight day; Akari, on breakthrough clinical data in pancreatic cancer; Sunshine, following regulatory approval for its generic A...
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value
We recently compiled a list of the 10 Best Biotech Stocks Under $10 to Buy. Corbus Pharmaceuticals Holdings, Inc. is among the best biotech stocks. TheFly reported on April 7 that Mizuho raised its p...
Get Corbus Pharmaceuticals Holding fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.